ALPA
Market cap | $0.00 |
---|---|
Enterprise Value | $4.23 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.01 |
Beta | 0 |
Outstanding Shares | 18,629,730 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -18.52 |
---|---|
PEG | 26.97 |
Price to Sales | -9.8 |
Price to Book Ratio | -9.8 |
Enterprise Value to Revenue | -1.33 |
Enterprise Value to EBIT | 0.95 |
Enterprise Value to Net Income | 2 |
Total Debt to Enterprise | 1.18 |
Debt to Equity | -1.31 |
No data
No data
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tib...